LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic ...Middle East

PR Newswire - News
SEOUL, South Korea, Aug. 1, 2021 /PRNewswire/ -- LISCure Biosciences, Inc. ("LISCure") has entered into a know-how license and development collaboration agreement, and stock purchase agreement with Mayo Clinic to advance LISCure's microbiome therapeutics in non-alcoholic steatohepatitis...

Read More Details
Finally We wish PressBee provided you with enough information of ( LISCure Biosciences Announces Know-How License Agreement and Stock Purchase Agreement with Mayo Clinic )

Also on site :



Latest News